Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, Neri I, Ortoncelli M, Schena D, Stingeni L, Hansel K, Piccolo V, Di Brizzi V, Potenza C, Tolino E, Bianchi L, Manti S, De Pasquale R, Di Lernia V, Caminiti L, Galli E, Coppo P, Chiricozzi A, De Simone C, Guerriero C, Amoruso FG, Provenzano E, Leonardi S, Licari A, Marseglia GL, Palermo A, Di Pillo S, Russo D, Moschese V, Patella V, Peduto T, Ferreli C, Zangari P, Veronese F, Berti SF, Gruber M, Pezzolo E, Termine S, Satta R, Dragoni F, Esposito M, Fargnoli MC, Chiodini P, Vallone Y, di Vico F, Picone V, Napolitano M. Patruno C, et al. Among authors: ortoncelli m. J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602. J Dermatolog Treat. 2023. PMID: 37580895 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 38212914
Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT, Viola R, Fierro MT, Ribero S, Ortoncelli M. Giura MT, et al. Among authors: ortoncelli m. Dermatol Ther. 2020 Jan;33(1):e13201. doi: 10.1111/dth.13201. Epub 2019 Dec 28. Dermatol Ther. 2020. PMID: 31856368
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: ortoncelli m. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis.
Nettis E, Ortoncelli M, Pellacani G, Foti C, Di Leo E, Patruno C, Rongioletti F, Argenziano G, Ferrucci SM, Macchia L, Napolitano M, Ribero S, Bonzano L, Romita P, Di Bona D, Bennardo L, Piras V, Calabrese G, Tavecchio S, Detoraki C, Carbonara M, Fabbrocini G. Nettis E, et al. Among authors: ortoncelli m. J Investig Allergol Clin Immunol. 2020;30(6):448-450. doi: 10.18176/jiaci.0519. Epub 2020 May 6. J Investig Allergol Clin Immunol. 2020. PMID: 32376512 Free article. No abstract available.
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.
Nettis E, Ferrucci SM, Ortoncelli M, Pellacani G, Foti C, Di Leo E, Patruno C, Rongioletti F, Argenziano G, Macchia L, Tavecchio S, Napolitano M, Ribero S, Bonzano L, Romita P, Di Bona D, Nisticò SP, Piras V, Calabrese G, Detoraki C, Carbonara M, Fabbrocini G. Nettis E, et al. Among authors: ortoncelli m. J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):124-132. doi: 10.18176/jiaci.0641. Epub 2020 Aug 26. J Investig Allergol Clin Immunol. 2022. PMID: 32856595 Free article.
96 results